-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test is an affordable, accessible blood test that detects cancer in dogs.

H3K27Me3-nucleosome is a strong prognostic biomarker in Non-Small Cell Lung Cancer: interim results from the analysis of up to 832 patients at baseline
- Share
- Tweet
- Share on Facebook
- Share


Paper titled: H3K27Me3-nucleosome is a strong prognostic biomarker in Non-Small Cell Lung Cancer: interim results from the analysis of up to 832 patients at baseline
Marie Piecyk, Emmanuel Grolleau, Gaelle Lescuyer, Sébastien Couraud, Patrick Merle, Patrick Mas, Sébastien Larive, Michael Duruisseaux, Oriane Pelton, Gwenaelle Schnoering, Aristotelis Kotronoulas, Julie Candiracci, Marielle Herzog, Léa Payen1
Presented at ELCC 2025
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields